Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
Olga KantorHarold J BursteinTari A KingSteven ShakChristy A RussellArmando E GiulianoGabriel N HortobagyiEric P WinerLarissa A KordeJoseph A SparanoElizabeth A MittendorfPublished in: Annals of surgical oncology (2022)
Patients with T1-2N0 HR+HER2- breast cancer and a RS < 18 have an RFI similar to that of patients staged as PPS 1A by the current AJCC staging system, regardless of treatment, suggesting that the criteria for PPS 1A can be expanded to include a RS < 18.